Placebo to match LY, Mirikizumab, Placebo to Mirikizumab, Mirikizumab
J6E-MC-KWAN
Phase 2 small_molecule active
Quick answer
Placebo to match LY, Mirikizumab, Placebo to Mirikizumab, Mirikizumab for Ulcerative Colitis is a Phase 2 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Ulcerative Colitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active